213 related articles for article (PubMed ID: 8417823)
1. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer.
Duncan L; Purohit A; Howarth NM; Potter BV; Reed MJ
Cancer Res; 1993 Jan; 53(2):298-303. PubMed ID: 8417823
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
Selcer KW; Hegde PV; Li PK
Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
[TBL] [Abstract][Full Text] [Related]
3. The hydrolysis of estrone sulfate and dehydroepiandrosterone sulfate by MCF-7 human breast cancer cells.
MacIndoe JH
Endocrinology; 1988 Sep; 123(3):1281-7. PubMed ID: 2969800
[TBL] [Abstract][Full Text] [Related]
4. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
[TBL] [Abstract][Full Text] [Related]
5. Control of sulfatase activity by nomegestrol acetate in normal and cancerous human breast tissues.
Chetrite GS; Thomas JL; Shields-Botella J; Cortes-Prieto J; Philippe JC; Pasqualini JR
Anticancer Res; 2005; 25(4):2827-30. PubMed ID: 16080533
[TBL] [Abstract][Full Text] [Related]
6. Steroidal and nonsteroidal sulfamates as potent inhibitors of steroid sulfatase.
Woo LW; Howarth NM; Purohit A; Hejaz HA; Reed MJ; Potter BV
J Med Chem; 1998 Mar; 41(7):1068-83. PubMed ID: 9544207
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of placental estrone sulfatase activity and MCF-7 breast cancer cell proliferation by estrone-3-amino derivatives.
Selcer KW; Jagannathan S; Rhodes ME; Li PK
J Steroid Biochem Mol Biol; 1996 Sep; 59(1):83-91. PubMed ID: 9009241
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
Hejaz HA; Purohit A; Mahon MF; Reed MJ; Potter BV
J Med Chem; 1999 Aug; 42(16):3188-92. PubMed ID: 10447965
[TBL] [Abstract][Full Text] [Related]
9. Stilbene-based inhibitors of estrone sulfatase with a dual mode of action in human breast cancer cells.
Walter G; Liebl R; von Angerer E
Arch Pharm (Weinheim); 2004 Dec; 337(12):634-44. PubMed ID: 15597397
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of oestrone sulphatase activity by tibolone and its metabolites.
Purohit A; Malini B; Hooymans C; Newman SP
Horm Metab Res; 2002 Jan; 34(1):1-6. PubMed ID: 11832993
[TBL] [Abstract][Full Text] [Related]
11. Estradiol inhibits the estrone sulfatase activity in normal and cancerous human breast tissues.
Chetrite GS; Cortes-Prieto JC; Philippe JC; Pasqualini JR
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):289-92. PubMed ID: 17481887
[TBL] [Abstract][Full Text] [Related]
12. In vivo activity of 4-methylcoumarin-7-O-sulfamate, a nonsteroidal, nonestrogenic steroid sulfatase inhibitor.
Purohit A; Woo LW; Singh A; Winterborn CJ; Potter BV; Reed MJ
Cancer Res; 1996 Nov; 56(21):4950-5. PubMed ID: 8895749
[TBL] [Abstract][Full Text] [Related]
13. Estrogenicity, antiestrogenicity and estrone sulfatase inhibition of estrone-3-amine and estrone-3-thiol.
Selcer KW; Li PK
J Steroid Biochem Mol Biol; 1995 Mar; 52(3):281-6. PubMed ID: 7696150
[TBL] [Abstract][Full Text] [Related]
14. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
[TBL] [Abstract][Full Text] [Related]
15. Sulfation is rate limiting in the futile cycling between estrone and estrone sulfate in enriched periportal and perivenous rat hepatocytes.
Tan E; Pang KS
Drug Metab Dispos; 2001 Mar; 29(3):335-46. PubMed ID: 11181504
[TBL] [Abstract][Full Text] [Related]
16. Role, control and expression of estrone sulfatase and 17 beta-hydroxysteroid dehydrogenase activities in human breast cancer.
Pasqualini JR
Zentralbl Gynakol; 1997; 119 Suppl 2():48-53. PubMed ID: 9361395
[TBL] [Abstract][Full Text] [Related]
17. Development of novel steroid sulfatase inhibitors; II. TZS-8478 potently inhibits the growth of breast tumors in postmenopausal breast cancer model rats.
Saito T; Kinoshita S; Fujii T; Bandoh K; Fuse S; Yamauchi Y; Koizumi N; Horiuchi T
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):167-73. PubMed ID: 15084348
[TBL] [Abstract][Full Text] [Related]
18. Development of (p-O-sulfamoyl)-N-alkanoyl-phenylalkyl amines as non-steroidal estrone sulfatase inhibitors.
Kolli A; Chu GH; Rhodes ME; Inoue K; Selcer KW; Li PK
J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):31-40. PubMed ID: 10215035
[TBL] [Abstract][Full Text] [Related]
19. Action of danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary cancer cells.
Nguyen BL; Ferme I; Chetrite G; Pasqualini JR
J Steroid Biochem Mol Biol; 1993 Jul; 46(1):17-23. PubMed ID: 8338787
[TBL] [Abstract][Full Text] [Related]
20. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
Walter G; Liebl R; von Angerer E
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]